- Prior was 6.48m
Most Popular
Sponsored
GSK snaps up Nuvalent for $10.6B, boosting its oncology pipeline. A 39% surge for NVLT shareholders!
AVGO dips on guidance, but analysts see 20%+ upside. Is it a buy post-pullback?
China's exports jump 35% on AI boom, hitting 5-year highs. Semiconductors & rare earths lead the charge.
AI stocks tumble, S&P 500 faces worst day as Fed rate hike odds rise. Bubble fears loom.
Micron's 918% surge sparks debate: Is it time to sell? AI winner faces Fed shifts, but cash flow is strong.
Micron's 918% surge sparks buy/sell debate. Is its AI dominance sustainable or time to cash out?
Woodstock's AI trading joins MCP craze, offering data & analysis. Risks loom as regulators ponder AI's market role.
Sponsored
Must Read